EG24142A - Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition - Google Patents

Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition

Info

Publication number: EG24142A
Authority: EG; Egypt
Prior art keywords: preparing; preparation; pharmaceutical composition; crystalline monohydrate; monohydrate
Prior art date: 2000-10-12

Application number

EG20011058A

Inventor

Banholzer Rolf

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2001-10-09

Publication date

2008-08-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24142(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-10-09 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2008-08-06 Application granted granted Critical

2008-08-06 Publication of EG24142A publication Critical patent/EG24142A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

EG20011058A 2000-10-12 2001-10-09 Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition EG24142A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12

Publications (1)

Publication Number	Publication Date
EG24142A true EG24142A (en)	2008-08-06

Family

ID=7659568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG20011058A EG24142A (en)	2000-10-12	2001-10-09	Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition

Country Status (47)

Country	Link
EP (2)	EP1326862B1 (en)
JP (1)	JP3764422B2 (en)
KR (1)	KR100823860B1 (en)
CN (2)	CN1221549C (en)
AP (1)	AP1572A (en)
AR (2)	AR034389A1 (en)
AT (1)	ATE276253T1 (en)
AU (2)	AU2002214996B2 (en)
BG (1)	BG66161B1 (en)
BR (1)	BR0114584A (en)
CA (1)	CA2425539C (en)
CR (1)	CR6938A (en)
CZ (1)	CZ301841B6 (en)
DE (1)	DE50103666D1 (en)
DK (1)	DK1326862T3 (en)
DZ (1)	DZ3478A1 (en)
EA (1)	EA004381B1 (en)
EC (1)	ECSP034540A (en)
EE (1)	EE04567B1 (en)
EG (1)	EG24142A (en)
ES (1)	ES2228965T3 (en)
GE (1)	GEP20063905B (en)
HK (2)	HK1060567A1 (en)
HR (1)	HRP20030276B1 (en)
HU (1)	HU226830B1 (en)
IL (2)	IL155335A0 (en)
IS (1)	IS2339B (en)
MA (1)	MA25842A1 (en)
ME (2)	ME00243B (en)
MX (1)	MXPA03003221A (en)
MY (1)	MY126931A (en)
NO (1)	NO328465B1 (en)
NZ (1)	NZ525733A (en)
OA (1)	OA12403A (en)
PE (1)	PE20020422A1 (en)
PL (1)	PL207870B1 (en)
PT (1)	PT1326862E (en)
RS (1)	RS50218B (en)
SA (1)	SA01220412B1 (en)
SI (1)	SI1326862T1 (en)
SK (1)	SK287009B6 (en)
TR (1)	TR200402579T4 (en)
TW (1)	TW589313B (en)
UA (1)	UA74215C2 (en)
UY (2)	UY26962A1 (en)
WO (1)	WO2002030928A1 (en)
ZA (1)	ZA200302500B (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
MXPA03011718A (en) *	2001-06-22	2004-12-06	Boehringer Ingelheim Pharma	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug.
DE10212264A1 (en)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
DE10214263A1 (en) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA suspension formulations containing an anticholinergic
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (en)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
JP5165244B2 (en)	2003-11-03	2013-03-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Method for producing tiotropium salt, tiotropium salt and pharmaceutical composition containing the same
RS20060291A (en) *	2003-11-03	2008-06-05	Boehringer Ingelheim International Gmbh.,	Novel crystalline anhydride with anticholinergic effect
ES2350981T3 (en) *	2003-11-03	2011-01-28	Boehringer Ingelheim International Gmbh	PROCEDURE FOR THE PREPARATION OF NEW SALTS OF TIOTROPY.
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
DE102004016179A1 (en) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Compounds for the treatment of proliferative processes
NZ550797A (en)	2004-04-22	2010-08-27	Boehringer Ingelheim Int	Pharmaceutical combinations containing 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one for treating respiratory diseases
DE102004024454A1 (en)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ATE427108T1 (en)	2004-08-11	2009-04-15	Boehringer Ingelheim Pharma	MEDICINAL PRODUCTS CONTAINING ANTICHOLINERGICS FOR THE TREATMENT OF DISEASES OF THE URINARY TRACT
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (en)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modification of surfaces of lactose as adjuvant for use with powder inhalants
BRPI0517282A (en) *	2004-10-21	2008-10-07	Boehringer Ingelheim Int	inhaler blister
CA2600636A1 (en) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
WO2006114371A1 (en)	2005-04-28	2006-11-02	Boehringer Ingelheim International Gmbh	Novel compounds for treating inflammatory diseases
AU2006243238B2 (en)	2005-05-02	2012-05-24	Boehringer Ingelheim International Gmbh	Novel crystalline forms of tiotropium bromide
CN101203513A (en) *	2005-05-02	2008-06-18	贝林格尔·英格海姆国际有限公司	Novel crystalline forms of tiotropium bromide
CA2611902C (en) *	2005-06-15	2013-08-27	Boehringer Ingelheim International Gmbh	Tiotropium salts, compositions thereof, and processes for preparing same via tiotropium bicarbonate reacted with an acid
DE102005030733A1 (en)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
BRPI0614394A2 (en) *	2005-08-06	2011-03-29	Boehringer Ingelheim Int	use of tiotropium salts
ES2530991T3 (en)	2005-08-15	2015-03-09	Boehringer Ingelheim Int	Procedure for obtaining betamimetics
US20070086957A1 (en)	2005-10-10	2007-04-19	Thierry Bouyssou	Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (en) *	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Micronization process
CA2627729A1 (en) *	2005-12-19	2007-07-05	Sicor Inc.	Novel forms of tiotropium bromide and processes for preparation thereof
MX2007009987A (en) *	2005-12-19	2007-10-02	Sicor Inc	Pure and stable tiotropium bromide.
ME01205B (en) *	2006-01-04	2013-03-20	Boehringer Ingelheim Int	Use of tiotropium salts in the treatment of moderate persistent asthma
MX2007012313A (en)	2006-04-19	2007-11-21	Boehringer Ingelheim Int	Dihydrothienopyrimidines for the treatment of inflammatory diseases.
EP1847543A1 (en)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidines for the treatment of inflammatory diseases
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
EP2051714B1 (en)	2006-08-07	2011-04-13	Boehringer Ingelheim International GmbH	Drug combinations for the treatment of respiratory tract diseases
UY30550A1 (en)	2006-08-22	2008-03-31	Boehringer Ingelheim Int	NEW BETA-AGANISTAS ENANTIOMÉRICAMENTE PUROS, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
EP1923393A1 (en) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Crystalline form of tiotropium bromide and urea
EP1925295A1 (en)	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stable powder formulation containing a new antichinolinergic agent
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
WO2009050248A1 (en)	2007-10-19	2009-04-23	Boehringer Ingelheim International Gmbh	Substituted piperidino-dihydrothienopyrimidines
EP2093219A1 (en)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Crystalline enantiomer free salt form of a betamimetic and its use as medicine
WO2010011813A1 (en) *	2008-07-23	2010-01-28	Alkermes, Inc.	Complex of trospium and pharmaceutical compositions thereof
ES2551557T3 (en)	2008-12-19	2015-11-19	Boehringer Ingelheim International Gmbh	Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for the treatment of inflammations, asthma and COPD
EP2201934A1 (en)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en)	2009-03-06	2015-06-17	Mahmut Bilgic	New crystalline forms of tiotropium bromide
WO2011015883A1 (en)	2009-08-07	2011-02-10	Generics [Uk] Limited	Dichloromethane solvate of tiotropium bromide and its use
US8697719B2 (en)	2009-08-07	2014-04-15	Generics [Uk] Limited	Anhydrate of tiotropium bromide
EP2513086B1 (en)	2009-12-17	2015-04-29	Boehringer Ingelheim International GmbH	Novel antagonists for ccr2 and uses thereof
ES2524829T3 (en)	2009-12-17	2014-12-12	Boehringer Ingelheim International Gmbh	New CCR2 receptor antagonists and uses thereof
EP2528915B1 (en)	2010-01-29	2015-10-28	Boehringer Ingelheim International GmbH	Substituted naphthyridines and their use as syk kinase inhibitors
JP5646736B2 (en)	2010-05-12	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Novel CCR2 receptor antagonists, methods for their preparation, and their use as drugs
US8877745B2 (en)	2010-05-12	2014-11-04	Boehringer Ingelheim International Gmbh	CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011144501A1 (en)	2010-05-17	2011-11-24	Boehringer Ingelheim International Gmbh	Ccr2 antagonists and uses thereof
WO2011147772A1 (en)	2010-05-25	2011-12-01	Boehringer Ingelheim International Gmbh	Ccr2 receptor antagonists
US8962656B2 (en)	2010-06-01	2015-02-24	Boehringer Ingelheim International Gmbh	CCR2 antagonists
WO2012101013A1 (en)	2011-01-28	2012-08-02	Boehringer Ingelheim International Gmbh	Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (en) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Crystalline substances containing tiotropium bromide
JP5786257B2 (en)	2011-06-16	2015-09-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Novel selective CCR2 antagonist
EP2731941B1 (en)	2011-07-15	2019-05-08	Boehringer Ingelheim International GmbH	Novel and selective ccr2 antagonists
JP5860960B2 (en)	2011-07-26	2016-02-16	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Substituted quinolines and their use as pharmaceuticals
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (en) *	2011-11-28	2014-04-02	Zentiva, K.S.	Tiotropium bromide mixed solvate and process for preparing thereof
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
RS55919B1 (en)	2012-11-05	2017-09-29	Zentiva As	Stabilization of tiotropium solvates
EP2913332A1 (en) *	2014-02-27	2015-09-02	Euticals S.P.A.	Crystalline form of tiotropium bromide with lactose
ES2738416T3 (en)	2014-03-19	2020-01-22	Boehringer Ingelheim Int	SYK heteroaryl inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (en) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	CRYSTALLINE γ-MODIFICATION (1α,2β,4β,5α,7β)-7-[(HYDROXYDI-2-THIENYLACETYL)OXY]-9,9-DIMETHYL-3-OXA-9-AZONIATRICYCLO[3,3,1,02,4]NONANE BROMIDE MONOHYDRATE, METHOD OF THEREOF OBTAINING AND THEREOF-BASED PHARMACEUTICAL COMPOSITION
WO2017138896A1 (en)	2016-02-11	2017-08-17	Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti	Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) *	2016-11-04	2018-05-11	Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇	A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (en) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
EP0673240B1 (en) *	1992-12-09	1999-03-24	Boehringer Ingelheim Pharmaceuticals Inc.	Stabilized medicinal aerosol solution formulations
DE19834506A1 (en) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosal therapeutic system for the use of sildenafil
CA2338680C (en) *	1998-08-04	2008-10-14	Jago Research Ag	Medicinal aerosol formulations

2001
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/en active
- 2001-09-28 DE DE50103666T patent/DE50103666D1/en not_active Expired - Lifetime
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/en unknown
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/en active IP Right Grant
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/en active IP Right Grant
- 2001-09-28 ES ES01983510T patent/ES2228965T3/en not_active Expired - Lifetime
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active Active
- 2001-09-28 HU HU0301022A patent/HU226830B1/en unknown
- 2001-09-28 RS YU27303A patent/RS50218B/en unknown
- 2001-09-28 PL PL366041A patent/PL207870B1/en unknown
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/en not_active IP Right Cessation
- 2001-09-28 EE EEP200300171A patent/EE04567B1/en unknown
- 2001-09-28 CN CNB018171435A patent/CN1221549C/en not_active Ceased
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/en unknown
- 2001-09-28 DK DK01983510T patent/DK1326862T3/en active
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/en unknown
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/en not_active Expired - Lifetime
- 2001-09-28 PT PT01983510T patent/PT1326862E/en unknown
- 2001-09-28 AU AU1499602A patent/AU1499602A/en active Pending
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 OA OA1200300107A patent/OA12403A/en unknown
- 2001-09-28 IL IL15533501A patent/IL155335A0/en active IP Right Grant
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/en active Pending
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/en not_active Ceased
- 2001-09-28 EP EP01983510A patent/EP1326862B1/en not_active Expired - Lifetime
- 2001-09-28 SK SK436-2003A patent/SK287009B6/en not_active IP Right Cessation
- 2001-09-28 SI SI200130219T patent/SI1326862T1/en unknown
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/en active IP Right Grant
- 2001-09-28 AT AT01983510T patent/ATE276253T1/en active
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 EA EA200300457A patent/EA004381B1/en not_active IP Right Cessation
- 2001-09-28 UA UA2003054185A patent/UA74215C2/en unknown
- 2001-09-28 EP EP04016877A patent/EP1468998A1/en not_active Withdrawn
- 2001-10-02 SA SA01220412A patent/SA01220412B1/en unknown
- 2001-10-09 EG EG20011058A patent/EG24142A/en active
- 2001-10-09 TW TW090124963A patent/TW589313B/en active
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/en active IP Right Grant
- 2001-10-10 UY UY26962A patent/UY26962A1/en not_active Application Discontinuation
- 2001-10-12 AR ARP010104782A patent/AR034389A1/en active Pending
2003
- 2003-03-26 CR CR6938A patent/CR6938A/en unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/en active Active
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/en unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/en unknown
- 2003-04-09 IS IS6772A patent/IS2339B/en unknown
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-10 HR HR20030276A patent/HRP20030276B1/en not_active IP Right Cessation
- 2003-04-11 NO NO20031694A patent/NO328465B1/en not_active IP Right Cessation
2004
- 2004-05-20 HK HK04103583A patent/HK1060567A1/en not_active IP Right Cessation
2006
- 2006-06-07 HK HK06106478.2A patent/HK1086557A1/en not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/en unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
OA12403A (en)	2006-04-18
MXPA03003221A (en)	2004-12-03
CN100519558C (en)	2009-07-29
PE20020422A1 (en)	2002-06-28
HU226830B1 (en)	2009-11-30
CZ301841B6 (en)	2010-07-07
AU2002214996B2 (en)	2007-03-15
HUP0301022A3 (en)	2005-12-28
CA2425539C (en)	2007-04-03
NO20031694L (en)	2003-04-11
CR6938A (en)	2004-10-28
NO328465B1 (en)	2010-02-22
RS50218B (en)	2009-07-15
ATE276253T1 (en)	2004-10-15
NZ525733A (en)	2005-01-28
HRP20030276A2 (en)	2005-02-28
EA004381B1 (en)	2004-04-29
DE50103666D1 (en)	2004-10-21
PL366041A1 (en)	2005-01-24
PT1326862E (en)	2004-11-30
UA74215C2 (en)	2005-11-15
KR100823860B1 (en)	2008-04-21
AU1499602A (en)	2002-04-22
MY126931A (en)	2006-10-31
NO20031694D0 (en)	2003-04-11
CN1733761A (en)	2006-02-15
EA200300457A1 (en)	2003-10-30
EP1326862A1 (en)	2003-07-16
HK1086557A1 (en)	2006-09-22
YU27303A (en)	2006-05-25
SK4362003A3 (en)	2003-08-05
UY26962A1 (en)	2002-06-20
EP1326862B1 (en)	2004-09-15
BG66161B1 (en)	2011-09-30
AR034389A1 (en)	2004-02-25
HRP20030276B1 (en)	2006-02-28
PL207870B1 (en)	2011-02-28
ES2228965T3 (en)	2005-04-16
CA2425539A1 (en)	2003-04-11
SI1326862T1 (en)	2005-02-28
AR068527A2 (en)	2009-11-18
ME00243B (en)	2011-05-10
CN1469877A (en)	2004-01-21
AP2003002775A0 (en)	2003-03-31
BG107687A (en)	2003-09-30
WO2002030928A1 (en)	2002-04-18
IS2339B (en)	2008-02-15
EP1468998A1 (en)	2004-10-20
SK287009B6 (en)	2009-09-07
IL155335A (en)	2009-02-11
EE04567B1 (en)	2005-12-15
TR200402579T4 (en)	2004-12-21
SA01220412B1 (en)	2006-11-05
DZ3478A1 (en)	2002-04-18
HUP0301022A2 (en)	2003-10-28
IL155335A0 (en)	2003-11-23
GEP20063905B (en)	2006-08-25
HK1060567A1 (en)	2004-08-13
BR0114584A (en)	2003-08-26
IS6772A (en)	2003-04-09
DK1326862T3 (en)	2004-11-22
TW589313B (en)	2004-06-01
JP2004526668A (en)	2004-09-02
JP3764422B2 (en)	2006-04-05
ECSP034540A (en)	2003-07-25
CN1221549C (en)	2005-10-05
EE200300171A (en)	2003-06-16
KR20030042008A (en)	2003-05-27
MEP40008A (en)	2011-02-10
AP1572A (en)	2006-02-13
ZA200302500B (en)	2004-04-22
MA25842A1 (en)	2003-07-01
UY34901A (en)	2015-02-27

Publication	Publication Date	Title
EG24142A (en)	2008-08-06	Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition
EG24851A (en)	2010-10-27	Crystalline anticholinergic process for the preparation thereof for preparing a medicament
HUP0400932A3 (en)	2007-11-28	Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
HUP0300731A3 (en)	2006-05-29	Valsartan salts, process for their preparation and pharmaceutical compositions thereof
HUP0303524A3 (en)	2008-03-28	Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
AU5889701A (en)	2001-12-17	Novel oxazolidinone derivatives and a process for the preparation thereof
IL153167A0 (en)	2003-07-31	Phenyl derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy
HUP0203766A3 (en)	2008-01-28	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0203902A3 (en)	2003-07-28	Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
TWI319764B (en)	2010-01-21	Mercaptoacetylamide derivatives, a process for their preparation and their use
IL156662A0 (en)	2004-01-04	Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2001241056A1 (en)	2001-09-17	Spiro compounds, process for preparing the same and use thereof as drugs
HUP0302295A3 (en)	2007-03-28	Thienodibenzoazulene derivatives, process for their preparation and use thereof
HUP0302099A3 (en)	2009-08-28	Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
CZ2006533A3 (en)	2001-05-16	Amorphous ritonavir, methods for its preparation, its use, and a pharmaceutical composition comprising it
IL153505A0 (en)	2003-07-06	Dds compound and process for the preparation thereof
HUP0202322A3 (en)	2003-04-28	A substantially crystalline form of melagatran, process for obtaining it, pharmaceutical composition containing thereof and its use
AP1826A (en)	2008-02-08	A controlled release pharmaceutical composition and a process for preparing the same
HUP0200412A3 (en)	2002-11-28	New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use
HUP0200376A3 (en)	2003-07-28	Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
IL162101A (en)	2010-04-29	Crystalline form of a ribofuranosyluronamide derivative, pharmaceutical compositions comprising it, processes for its preparation and use thereof in the preparation of medicaments
AU8395901A (en)	2002-02-13	Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
EP1556364A4 (en)	2008-04-16	Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same
AU2001260083A1 (en)	2001-12-03	New pharmaceutical composition and the process for its preparation